We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+7.29%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$22.1B
AUM Growth
+$302M
Cap. Flow
-$1.3B
Cap. Flow %
-5.9%
Top 10 Hldgs %
11.41%
Holding
3,562
New
1,146
Increased
641
Reduced
606
Closed
971

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$148M
2
NFLX icon
Netflix
NFLX
+$119M
3
ABNB icon
Airbnb
ABNB
+$111M
4
XYZ
Block Inc
XYZ
+$89.5M
5
DHR icon
Danaher
DHR
+$88.6M

Top Sells

Rank Stock Value
1
CRL icon
Charles River Laboratories
CRL
+$212M
2
BABA icon
Alibaba
BABA
+$172M
3
ZTS icon
Zoetis
ZTS
+$133M
4
TRU icon
TransUnion
TRU
+$124M
5
BIDU icon
Baidu
BIDU
+$111M

Sector Composition

Rank Sector Weight
1 Healthcare 20.88%
2 Financials 13.4%
3 Consumer Discretionary 12.06%
4 Technology 11.2%
5 Communication Services 8.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DIA icon
1726
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$46B
$1.15M 0.01%
+3,329
New +$1.14M
USIO icon
1727
Usio Inc
USIO
$53.8M
$1.15M 0.01%
179,180
-64,753
-27% -$404K
GRTX
1728
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
$1.15M 0.01%
116,508
+62,394
+115% +$507K
ARAV
1729
DELISTED
Aravive, Inc. Common Stock
ARAV
$1.14M 0.01%
191,420
+128,610
+205% +$680K
FMX icon
1730
Fomento Económico Mexicano
FMX
$43.5B
$1.14M 0.01%
13,523
-79,894
-86% -$6.54M
JBL icon
1731
Jabil
JBL
$31.7B
$1.14M 0.01%
+19,648
New +$1.08M
XNCR icon
1732
Xencor
XNCR
$1.48B
$1.14M 0.01%
33,105
+9,638
+41% +$382K
APEN
1733
DELISTED
Apollo Endosurgery, Inc.
APEN
$1.14M 0.01%
140,824
-234,475
-62% -$1.61M
SMED
1734
DELISTED
Sharps Compliance Corp
SMED
$1.14M 0.01%
+110,491
New +$1.54M
TRGP icon
1735
Targa Resources
TRGP
$56.2B
$1.14M 0.01%
+25,575
New +$990K
PR
1736
Permian Resources
PR
$16.5B
$1.13M 0.01%
166,979
-540,024
-76% -$2.79M
GILD icon
1737
PUT
Gilead Sciences
GILD
$167B
$1.13M 0.01%
+16,400
New +$1.1M
X
1738
PUT
DELISTED
US Steel
X
$1.13M 0.01%
+47,100
New +$1.16M
EGHT icon
1739
8x8 Inc
EGHT
$271M
$1.13M 0.01%
+40,550
New +$1.15M
RDBXW
1740
CALL
DELISTED
Redbox Entertainment Inc. Warrant
RDBXW
$1.12M 0.01%
+112,874
New +$80.4K
CLSD
1741
DELISTED
Clearside Biomedical
CLSD
$1.12M 0.01%
15,363
-6,911
-31% -$321K
HCAQ
1742
DELISTED
HealthCor Catalio Acquisition Corp. Class A Ordinary Shares
HCAQ
$1.12M 0.01%
113,884
– –
RVMD icon
1743
Revolution Medicines
RVMD
$39.1B
$1.11M 0.01%
+35,031
New +$1.22M
HUMAW icon
1744
CALL
Humacyte Inc Warrant
HUMAW
$1.4M
$1.11M 0.01%
108,979
+32,979
+43% +$87.5K
CLNE icon
1745
Clean Energy Fuels
CLNE
$421M
$1.11M 0.01%
+109,295
New +$1.13M
SBOW
1746
DELISTED
SilverBow Resources, Inc.
SBOW
$1.1M 0.01%
47,519
+11,499
+32% +$175K
IPOD
1747
DELISTED
Social Capital Hedosophia Holdings Corp. IV
IPOD
$1.1M 0.01%
+106,135
New +$1.12M
CDZI icon
1748
Cadiz
CDZI
$259M
$1.1M 0.01%
80,766
+98
+0.1% +$1.17K
PICK icon
1749
iShares MSCI Global Metals & Mining Producers ETF
PICK
$2.18B
$1.09M ﹤0.01%
+24,159
New +$1.12M
CHE icon
1750
Chemed
CHE
$6.87B
$1.09M ﹤0.01%
+2,288
New +$1.1M
68 69
70
71 72

Similar funds

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS) West Sacramento, California $94.5B AUM 29.33% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return

Marshall Wace's Q2 2021 Portfolio in Review

As of Q2 2021, Marshall Wace held 3,562 positions worth $22.1B, up 1.4% from $21.8B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Marshall Wace withdrew a net $1.3B in Q2 2021, closing 971 positions and reducing 606 holdings. Its most notable exit was Pinterest, an estimated $88.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Marshall Wace opened a new position in West Pharmaceutical worth $55.8M.

  • Marshall Wace's largest Q2 2021 buy was West Pharmaceutical: 155,316 shares worth $55.8M.
  • Marshall Wace added most to Biogen in Q2 2021, an estimated $148M increase.
  • Marshall Wace's biggest Q2 2021 reduction was Charles River Laboratories, cutting an estimated $212M.
  • Marshall Wace fully exited Pinterest in Q2 2021, selling an estimated $88.8M.
  • Marshall Wace's ten largest holdings make up 11% of its $22.1B portfolio in Q2 2021.
  • Marshall Wace opened 1,146 new positions and closed 971 in Q2 2021.
  • Marshall Wace's portfolio value rose 1.4% quarter-over-quarter to $22.1B.

Based on Marshall Wace's 13F filing for Q2 2021, filed 13 Aug 2021.